- Home
- CNTB vs VATE Comparison
CNTB vs VATE Comparison
Compare CNTB & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNTB | VATE |
|---|---|---|
| Founded | 2012 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 140.4M | 103.5M |
| IPO Year | 2020 | 1996 |
Fundamental Metrics
Financial Performance| Metric | CNTB | VATE |
|---|---|---|
| Price | $2.48 | $7.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.67 | N/A |
| AVG Volume (30 Days) | 513.0K | ★ 657.4K |
| Earning Date | 08-13-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $64,000.00 | ★ $1,246,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 12.55 |
| 52 Week Low | $1.23 | $3.75 |
| 52 Week High | $3.82 | $21.30 |
Technical Indicators
Market Signals| Indicator | CNTB | VATE |
|---|---|---|
| Relative Strength Index (RSI) | 58.62 | 42.31 |
| Support Level | $2.30 | $6.41 |
| Resistance Level | $2.69 | $8.20 |
| Average True Range (ATR) | 0.18 | 0.44 |
| MACD | 0.00 | 0.12 |
| Stochastic Oscillator | 76.60 | 22.75 |
Price Performance
Historical ComparisonAbout CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments. Its segments include Infrastructure, Life Sciences and Spectrum, and Other segment. Through its subsidiaries it provides fully integrated structural and steel construction services; supports healthcare and biotechnology product development; and operates Over-The-Air (OTA) broadcasting stations across the United States (U.S.) including Puerto Rico.